Unjha Formulations share price
You have to be logged in to add this to Watchlist.- ₹26.90(-0.19%)November 17, 2025 12:10:51 PM IST
- NSE
- BSE
- Vol : 0.51K (NSE + BSE)Last 20 day avg : 3.98 K
Unjha Formulations is trading -0.19% lower at Rs 26.90 as compared to its last closing price. Unjha Formulations has been trading in the price range of 26.95 & 26.90. Unjha Formulations has given -11.26% in this year & 14.19% in the last 5 days. Unjha Formulations has TTM P/E ratio 95.16 as compared to the sector P/E of 51.80.The company posted a net profit of 0.39 Crores in its last quarter.Listed peers of Unjha Formulations include Shamrock Industrial (-%), Decipher Labs (6.90%), Colinz Laboratories (4.70%).The Mutual Fund holding in Unjha Formulations was at -% in . The MF holding has - from the last quarter. The FII holding in Unjha Formulations was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Nov 17, 2025, 09:13 AM UTC
- BetaLow volatility-0.65Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable
The company's revenue fell during June quarter by 8.55% from Rs 3.95 crore to Rs 3.61 crore, year-on-year- The company's profit declined by 44.21% year-on-year during the June quarter, dropping from Rs 0.70 crore to Rs 0.39 crore
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 26.50
- R2
- 29.99
- R3
- 32.19
- S1
- 20.81
- S2
- 18.61
- S3
- 15.12
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Shamrock Industrial | Neutral | 18.48 | - | 10.03 | - | 5.96 | - | - |
| Decipher Labs | Moderately Bullish | 10.69 | 6.90 | 10.69 | - | 0.42 | - | - |
| Colinz Laboratories | Moderately Bullish | 44.75 | 4.70 | 11.28 | 22.32 | 1.17 | - | - |
| Beryl Drugs | Moderately Bearish | 23.25 | -2.92 | 11.79 | 20.37 | 1.24 | - | 18.26 |
| Unjha Formulations | Bullish | 26.90 | -0.19 | 12.05 | 26.59 | 3.44 | - | - |
- Promoter(s) holding is moderate at 36.92%
- FIIs are not invested in this company
- Mutual Funds are not invested in this company.
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-10 | Quarterly Results |
| 2025-08-06 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-03-17 | Others |
| 2025-02-04 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE576D01015
- BSE Code531762
- NSE Code
Unjha Formulations is trading at 26.90 as on Mon Nov 17 2025 06:40:51. This is -0.19% lower as compared to its previous closing price of 26.95.
The market capitalization of Unjha Formulations is 12.05 Cr as on Mon Nov 17 2025 06:40:51.
The 52 wk high for Unjha Formulations is 35.18 whereas the 52 wk low is 19.99
Unjha Formulations can be analyzed on the following key metrics -
- TTM P/E: 95.16
- Sector P/E: 51.80
- Dividend Yield: 0.00%
- D/E ratio: -
Unjha Formulations reported a net profit of 0.41 Cr in 2025.